CC
CVS icon

Copperleaf Capital’s CVS Health CVS Stock Holding History

Copperleaf Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,905
Closed -$560K – 93
2024
Q3 		$560K Sell
8,905
-494
-5% -$28.8K 0.43% 67
2024
Q2 		$555K Buy
9,399
+96
+1% +$6K 0.44% 65
2024
Q1 		$742K Buy
9,303
+54
+0.6% +$4.13K 0.64% 49
2023
Q4 		$730K Buy
9,249
+3,956
+75% +$282K 0.74% 46
2023
Q3 		$370K Sell
5,293
-963
-15% -$68.2K 0.4% 56
2023
Q2 		$432K Sell
6,256
-246
-4% -$17.5K 0.41% 51
2023
Q1 		$483K Buy
6,502
+88
+1% +$7.38K 0.48% 44
2022
Q4 		$598K Sell
6,414
-176
-3% -$17K 0.69% 38
2022
Q3 		$628K Buy
6,590
+232
+4% +$23K 0.68% 42
2022
Q2 		$589K Sell
6,358
-44
-0.7% -$4.29K 0.6% 46
2022
Q1 		$648K Buy
6,402
+21
+0.3% +$2.21K 0.58% 45
2021
Q4 		$658K Sell
6,381
-211
-3% -$19.5K 0.57% 45
2021
Q3 		$559K Buy
6,592
+122
+2% +$10.2K 0.54% 45
2021
Q2 		$540K Sell
6,470
-34
-0.5% -$2.78K 0.53% 48
2021
Q1 		$489K Buy
+6,504
New +$474K 0.52% 46

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Copperleaf Capital's CVS Position: Q4 2024 in Review

Copperleaf Capital sold out of CVS Health (CVS) in Q4 2024, closing a stake of 8,905 shares — an estimated $560K sold.

Copperleaf Capital first reported a position in CVS in Q1 2021 and held it in 15 quarters. The position peaked at $742K in Q1 2024. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Copperleaf Capital reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Copperleaf Capital sold 8,905 CVS Health shares in Q4 2024, an estimated $560K.
  • Copperleaf Capital first reported a position in CVS Health in Q1 2021 and held it in 15 quarters.
  • Copperleaf Capital's CVS Health position peaked at $742K in Q1 2024.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Copperleaf Capital's 13F filing for Q4 2024, filed 30 Jan 2025.